IDEAYA Biosciences to Participate in Investor Conferences in March 2023

SOUTH SAN FRANCISCO, Calif., March 1, 2023 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences in…

Advertisement — Advertise with Biotech Networks